Drug Shortage Report for HEPARIN SODIUM INJECTION, USP
| Report ID | 253985 |
| Drug Identification Number | 02392453 |
| Brand name | HEPARIN SODIUM INJECTION, USP |
| Common or Proper name | HEPARIN SODIUM INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPARIN SODIUM |
| Strength(s) | 10000UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 0.5mL |
| ATC code | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-04-30 |
| Estimated end date | 2025-05-22 |
| Actual end date | 2025-05-22 |
| Shortage status | Actual shortage |
| Updated date | 2025-05-12 |
| Company comments | Fresenius Kabi Canada is pleased to advise that this product will be made available earlier than originally communicated. It will be available at Ontario distribution centres by May 22, 2025, and at all other distribution centres by May 26, 2025 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2025-05-12 | French | Compare |
| v6 | 2025-05-12 | English | Compare |
| v5 | 2025-05-12 | French | Compare |
| v4 | 2025-05-12 | English | Compare |
| v3 | 2025-05-01 | English | Compare |
| v2 | 2025-04-03 | French | Compare |
| v1 | 2025-04-03 | English | Compare |
Showing 1 to 7 of 7